244 related articles for article (PubMed ID: 33677993)
1. Combined Treatment with Bone Marrow-Derived Mesenchymal Stem Cells and Exendin-4 Promotes Islet Regeneration in Streptozotocin-Induced Diabetic Rats.
Song X; Sun X; Hao H; Han Q; Han W; Mu Y
Stem Cells Dev; 2021 May; 30(9):502-514. PubMed ID: 33677993
[TBL] [Abstract][Full Text] [Related]
2. The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats.
Kaya-Dagistanli F; Ozturk M
Acta Histochem; 2013 Jul; 115(6):577-86. PubMed ID: 23351716
[TBL] [Abstract][Full Text] [Related]
3. Exendin-4 potentiates insulinotropic action partly via increasing beta-cell proliferation and neogenesis and decreasing apoptosis in association with the attenuation of endoplasmic reticulum stress in islets of diabetic rats.
Kwon DY; Kim YS; Ahn IS; Kim DS; Kang S; Hong SM; Park S
J Pharmacol Sci; 2009 Dec; 111(4):361-71. PubMed ID: 20019445
[TBL] [Abstract][Full Text] [Related]
4. Effects of prolonged exendin-4 administration on entero-insular axis of normal and streptozotocin-induced diabetic rats.
Malendowicz LK; Macchi C; Nussdorfer GG; Nowak KW; Zyterska A; Ziolkowska A
Int J Mol Med; 2003 Jun; 11(6):763-6. PubMed ID: 12736719
[TBL] [Abstract][Full Text] [Related]
5. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
[TBL] [Abstract][Full Text] [Related]
6. Association of glucagon-like peptide-1 receptor-targeted imaging probe with in vivo glucagon-like peptide-1 receptor agonist glucose-lowering effects.
Murakami T; Fujimoto H; Fujita N; Hamamatsu K; Yabe D; Inagaki N
J Diabetes Investig; 2020 Nov; 11(6):1448-1456. PubMed ID: 32323451
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat.
Dong QY; Chen L; Gao GQ; Wang L; Song J; Chen B; Xu YX; Sun L
Clin Invest Med; 2008 Dec; 31(6):E328-37. PubMed ID: 19032902
[TBL] [Abstract][Full Text] [Related]
8. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B
Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-Like Peptide 1 Increases β-Cell Regeneration by Promoting α- to β-Cell Transdifferentiation.
Lee YS; Lee C; Choung JS; Jung HS; Jun HS
Diabetes; 2018 Dec; 67(12):2601-2614. PubMed ID: 30257975
[TBL] [Abstract][Full Text] [Related]
11. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
Sahraoui A; Winzell MS; Gorman T; Smith DM; Skrtic S; Hoeyem M; Abadpour S; Johansson L; Korsgren O; Foss A; Scholz H
PLoS One; 2015; 10(3):e0121204. PubMed ID: 25793295
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
Li Y; Hansotia T; Yusta B; Ris F; Halban PA; Drucker DJ
J Biol Chem; 2003 Jan; 278(1):471-8. PubMed ID: 12409292
[TBL] [Abstract][Full Text] [Related]
13. Functional β-Cell Differentiation of Small-Tail Han Sheep Pancreatic Mesenchymal Stem Cells and the Therapeutic Potential in Type 1 Diabetic Mice.
Zhang S; Yin J; Ji H; Wang Q; Yang Q; Lai J; Sun Y; Guan W; Chen P
Pancreas; 2020 Aug; 49(7):947-954. PubMed ID: 32658079
[TBL] [Abstract][Full Text] [Related]
14. A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis.
Cho JM; Jang HW; Cheon H; Jeong YT; Kim DH; Lim YM; Choi SH; Yang EK; Shin CY; Son MH; Kim SH; Kim HJ; Lee MS
Diabetes Res Clin Pract; 2011 Jan; 91(1):72-9. PubMed ID: 21093089
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Optimization, and Biological Evaluation of Corrinated Conjugates of the GLP-1R Agonist Exendin-4.
Tinsley IC; Borner T; Swanson ML; Chepurny OG; Doebley SA; Kamat V; Sweet IR; Holz GG; Hayes MR; De Jonghe BC; Doyle RP
J Med Chem; 2021 Mar; 64(6):3479-3492. PubMed ID: 33677970
[TBL] [Abstract][Full Text] [Related]
16. Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes.
Tanday N; English A; Lafferty RA; Flatt PR; Irwin N
Front Endocrinol (Lausanne); 2021; 12():674704. PubMed ID: 34054734
[TBL] [Abstract][Full Text] [Related]
17. Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia.
Boumaza I; Srinivasan S; Witt WT; Feghali-Bostwick C; Dai Y; Garcia-Ocana A; Feili-Hariri M
J Autoimmun; 2009 Feb; 32(1):33-42. PubMed ID: 19062254
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4, a glucagon-like peptide-1 analogue, accelerates diabetic wound healing.
Roan JN; Cheng HN; Young CC; Lee CJ; Yeh ML; Luo CY; Tsai YS; Lam CF
J Surg Res; 2017 Feb; 208():93-103. PubMed ID: 27993221
[TBL] [Abstract][Full Text] [Related]
19. Synergy Between Gαz Deficiency and GLP-1 Analog Treatment in Preserving Functional β-Cell Mass in Experimental Diabetes.
Brill AL; Wisinski JA; Cadena MT; Thompson MF; Fenske RJ; Brar HK; Schaid MD; Pasker RL; Kimple ME
Mol Endocrinol; 2016 May; 30(5):543-56. PubMed ID: 27049466
[TBL] [Abstract][Full Text] [Related]
20. Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia.
Xin Y; Jiang X; Wang Y; Su X; Sun M; Zhang L; Tan Y; Wintergerst KA; Li Y; Li Y
PLoS One; 2016; 11(1):e0145838. PubMed ID: 26756576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]